Long-term clinical outcomes of drug-eluting stents vs bare-metal stents in Chinese patients

Clinical Cardiology

Volumn 33, Issue 6, 2010, Pages

  Ho, Hee Hwa ^a,b   Pong, Vincent ^a,b   Siu, Chung Wah ^a,b,c   Jim, Man Hong ^b   Miu, Raymond ^a,c   Yiu, Kai Hang ^a,c   Ko, Ryan ^a,c   Tse, Hung Fat ^a,c   Kwok, On Hing ^b   Chow, Wing Hing ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b GRANTHAM HOSPITAL   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARE METAL STENT; CHINESE; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT; PERCUTANEOUS CORONARY INTERVENTION; REVASCULARIZATION; RISK ASSESSMENT; STENT THROMBOSIS; AGED; ANGIOCARDIOGRAPHY; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; ETHNOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; STENT; THROMBOSIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; ANGIOPLASTY, BALLOON, CORONARY; KAPLAN-MEIER ESTIMATE;

METAL;

EID: 77953836397     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20655     Document Type: Article

References (32)

1. Morice MC, Serruys PW, Sousa JE, et al. A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularisation. N Engl J Med. 2002;346:1773-1780.
2. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315-1323.
3. Grube E, Silber S, Hauptmann KE, et al. TAXUS I: six and twelve-month results from a randomised, double blind trial on a slow release paclitaxel-eluting stent for de novo coronary lesions. Circulation. 2003;107:38-42.
4. Stone GW, Ellis SG, Cox DA, et al. A polymer based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221-231.
5. Schofer J, Schlüter M, Gershlick AH, et al; E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: a double-blind randomised controlled trial (E-SIRIUS). Lancet. 2003;362: 1093-1099.
6. Ge L, Iakovou I, Cosgrave J, et al. Immediate and mid-term outcomes of sirolimus-eluting stents implantation for chronic total occlusions. Eur Heart J. 2005;26:1056-1062.
7. Kastrati A, Mehilli J, von Beckerath N, et al; ISAR-DESIRE Study Investigators. Sirolimus-eluting stent of paclitaxel-eluting stent versus balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomised controlled trial. JAMA. 2005;293:165-171.
8. Ellis SG, Kandzari D, Kereiakes DJ, et al. Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularisation in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study. J Invasive Cardiol. 2007;19(10):404-409.
9. Cheiffo A, Stankovic G, Bonizzoni E, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation. 2005;111:791-795.
10. Lemos PA, Saia F, Hofma SH, et al. Short and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients in acutemyocardial infarction. J Am Coll Cardiol. 2004;43:704-708.
11. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data froma large two-institutional cohort study. Lancet. 2007;369:667-678.
12. Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first generation drug-eluting stents. A cause of concern. Circulation. 2007;1155:1440-1455.
13. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al; for the BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare metal stents. J Am Coll Cardiol. 2006;48:2584-2591.
14. Lagerqvist B, James SK, Stenestrand U, et al. Long term outcomes with drug-eluting stents versus baremetal stents in Sweden. N Engl J Med. 2007;356:1009-1019.
15. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus and paclitaxel eluting coronary stents. N Engl J Med. 2007;356:998-1008.
16. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare metal stents. N Engl J Med. 2007;356:1030-1039.
17. Spaulding C, Daemen J, Boersma E, et al. A pooled analysis of data comparing sirolimus-eluting stents with bare metal stents. N Engl J Med. 2007;356:989-997. (Pubitemid 46376799)
18. Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare metal stents: a collaborative network meta-analysis. Lancet. 2007;370:937-948.
19. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomised clinical trials of drug-eluting stents. N Engl J Med. 2007;356(10):1020-1029. (Pubitemid 46376802)
20. Cutlip DE, Windecker S, Mehran R, et al; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115(17):2344-2351.
21. Luscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis:biological mechanisms and clinical implications. Circulation. 2007;115:1051-1058. (Pubitemid 46328299)
22. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193-202. (Pubitemid 43929240)
23. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-2130.
24. Virmani R, Guagliumi G, Farb A, et al. Localised hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation. 2004;109:701-705.
25. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159-168. (Pubitemid 46089732)
26. Jensen LO, Maeng M, Kaltoft A, et al. Stent thrombosis, myocardial infarction and death after drug-eluting and bare metal stent coronary interventions. J Am Coll Cardiol. 2007;50:463-470.
27. Nordmann AJ, Briell M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting verses bare metal stents in coronary artery disease. Eur Heart J. 2006;277:2784-2814.
28. Stone GW, Ellis SG, Colombo A, et al. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation. 2007;115:2842-2847. (Pubitemid 46869671)
29. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-495.
30. Fischman DL, Leon MB,Baim DS, et al. Arandomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
31. Walters DL, Harding SA, Walsh CR, et al. Acute coronary syndrome is a common clinical presentation of in-stent restenosis. Am J Cardiol. 2002;89:491-494.
32. Chen MS, John JM, Chew DP, et al. Bare metal stent restenosis is not a benign clinical entity. Am Heart J. 2006;151:1260-1264.